Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Unaudited standalone and Consolidated financial results for the quarter an Half Year ended on September 30, 2026.

Date: October 24, 2026 Corporate Relations Department BSE Limited Floor 25, P.J. Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 541096 Dear Sir/Madam, Subject: Intimation of Board Meeting. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the company is scheduled to be held on Thursday, October 29, 2026 at the registered office of the company to consider, approve and take on record the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2026 and to consider any other business with the permission of the Chair. Trading Window Closure pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and its immediate relatives, the Trading Window for dealing in securities of the company for all the Designated persons has already been closed with effect from Thursday, October 01, 2026 till Forty-eight (48) hours after the declaration of the said financial results of the company. The notice is also available on the website of the Company at www.bplindia.in You are requested to take the same on record. Thanking You, For, Bharat Parenterals Limited Mr. Sharmin Soni Company Secretary & Compliance Officer ICSI Membership No: A-75694 Place: Vadodara